Idorsia
Dr. Marco Borer is an accomplished legal professional with extensive experience in pharmaceutical law. Currently serving as Director and Senior Legal Counsel at Idorsia Pharmaceuticals Ltd since May 2021, Dr. Borer has previously held legal positions at Tillotts Pharma AG and Novartis. Dr. Borer began a professional career at Meyerlustenberger Lachenal Ltd. as a Junior Associate and at a law firm as a Legal Trainee. Academic credentials include a PhD in Law and a Master of Law from the University of Basel, coupled with legal training at the District Court Dorneck-Thierstein, demonstrating a solid foundation in legal expertise.
This person is not in any teams
This person is not in any offices
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.